相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of a High-Content Screening Assay Using Whole-Well Imaging of Transformed Phenotypes
Christina N. Ramirez et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
Comparison of Luminescence ADP Production Assay and Radiometric Scintillation Proximity Assay for Cdc7 Kinase
Toshimitsu Takagi et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2011)
Integrated analysis of receptor activation and downstream signaling with EXTassays
Anna Botvinnik et al.
NATURE METHODS (2010)
In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays
Hernan E. Grecco et al.
NATURE METHODS (2010)
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
Mark F. Ciaccio et al.
NATURE METHODS (2010)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
William Pao et al.
NATURE REVIEWS CANCER (2010)
Multiplexed Evaluation of a Cell-Based Assay for the Detection of Antidrug Neutralizing Antibodies to Panitumumab in Human Serum Using Automated Fluorescent Microscopy
Jason Pennucci et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling
Mark Sevecka et al.
NATURE METHODS (2006)
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity
Shem Patyna et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Chunjing Wu et al.
MOLECULAR CANCER (2005)
Identification of novel extracellular signal-regulated kinase docking domain inhibitors
CN Hancock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Quantitative methods for the analysis of protein phosphorylation in drug development
DM Olive
EXPERT REVIEW OF PROTEOMICS (2004)
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
AM O'Farrell et al.
BLOOD (2003)
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors
S Blencke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phloretin differentially inhibits volume-sensitive and cyclic AMP-activated, but not Ca-activated, Cl- channels
HT Fan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity
MS Shearman et al.
BIOCHEMISTRY (2000)
分享论文
